DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 50601 - 50625 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▲ Gene Name UniProt ID
C0007134 Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0000889 Acanthosis Nigricans ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0085636 Photophobia ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0013238 Dry Eye Syndromes ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0162309 Adrenoleukodystrophy ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C1527231 Adrenomyeloneuropathy ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0011603 Dermatitis ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0027651 Neoplasms ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0020456 Hyperglycemia ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0005697 Neurogenic Urinary Bladder ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0011849 Diabetes Mellitus ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011847 Diabetes ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C1306459 Primary malignant neoplasm ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0020456 Hyperglycemia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0002395 Alzheimer's Disease ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011265 Presenile dementia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011860 Diabetes Mellitus, Non-Insulin-Dependent ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0031117 Peripheral Neuropathy ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0524620 Metabolic Syndrome X ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0020459 Hyperinsulinism ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C2239176 Liver carcinoma ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0233794 Memory impairment ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0086132 Depressive Symptoms ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011854 Diabetes Mellitus, Insulin-Dependent ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024